FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2914792039> ?p ?o ?g. }

• W2914792039 endingPage "1257" @default.
• W2914792039 startingPage "1246" @default.
• W2914792039 abstract "Breast cancer is one of the leading fatal diseases for women worldwide who cannot have surgery typically have to rely on systemic chemotherapy to extend their survival. Doxorubicin (DOX) is one of the most commonly used chemotherapeutic agents against breast cancer, but acquired resistance to DOX can seriously impede the efficacy of chemotherapy, leading to poor prognosis and recurrences of cancer. Resveratrol (RES) is a phytoalexin with pharmacological antitumor properties, but its underlying mechanisms are not clearly understood in the treatment of DOX-resistant breast cancer. We used cell viability assays, cell scratch tests, and transwell assays combined with Western blotting and immunofluorescent staining to evaluate the effects of RES on chemoresistance and the epithelial-mesenchymal transitions (EMTs) in adriamycin-resistant MCF7/ADR breast cancer cells, and to investigate its underlying mechanisms. The results showed that a treatment of RES combining with DOX effectively inhibited cell growth, suppressed cell migration, and promoted cell apoptosis. RES reversed EMT properties of MCF7/ADR cells by modulating the connection between SIRT1 and β-catenin, which provides a hopeful therapeutic avenue to conquer DOX-resistance and thereby prolong survival rates in breast cancer patients." @default.
• W2914792039 created "2019-02-21" @default.
• W2914792039 creator A5000965108 @default.
• W2914792039 creator A5003919302 @default.
• W2914792039 creator A5004243536 @default.
• W2914792039 creator A5004780683 @default.
• W2914792039 creator A5020254575 @default.
• W2914792039 creator A5034618391 @default.
• W2914792039 creator A5062251921 @default.
• W2914792039 date "2019-01-29" @default.
• W2914792039 modified "2023-10-11" @default.
• W2914792039 title "Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer" @default.
• W2914792039 cites W1856175162 @default.
• W2914792039 cites W1964825240 @default.
• W2914792039 cites W1977186103 @default.
• W2914792039 cites W1985235736 @default.
• W2914792039 cites W1986877767 @default.
• W2914792039 cites W1996382897 @default.
• W2914792039 cites W1999259541 @default.
• W2914792039 cites W1999504198 @default.
• W2914792039 cites W2010338855 @default.
• W2914792039 cites W2065629669 @default.
• W2914792039 cites W2112238025 @default.
• W2914792039 cites W2141176449 @default.
• W2914792039 cites W2169601017 @default.
• W2914792039 cites W2170011121 @default.
• W2914792039 cites W2171313040 @default.
• W2914792039 cites W2258531487 @default.
• W2914792039 cites W2295552376 @default.
• W2914792039 cites W2342252259 @default.
• W2914792039 cites W2541390219 @default.
• W2914792039 cites W2581145348 @default.
• W2914792039 cites W2611533960 @default.
• W2914792039 cites W2619978475 @default.
• W2914792039 cites W2729738977 @default.
• W2914792039 cites W2735277730 @default.
• W2914792039 cites W2756722785 @default.
• W2914792039 cites W2764020816 @default.
• W2914792039 cites W2767812833 @default.
• W2914792039 cites W2771136768 @default.
• W2914792039 cites W2772364140 @default.
• W2914792039 cites W2782543572 @default.
• W2914792039 cites W2783337717 @default.
• W2914792039 doi "https://doi.org/10.1002/cam4.1993" @default.
• W2914792039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6434195" @default.
• W2914792039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30697969" @default.
• W2914792039 hasPublicationYear "2019" @default.
• W2914792039 type Work @default.
• W2914792039 sameAs 2914792039 @default.
• W2914792039 citedByCount "52" @default.
• W2914792039 countsByYear W29147920392019 @default.
• W2914792039 countsByYear W29147920392020 @default.
• W2914792039 countsByYear W29147920392021 @default.
• W2914792039 countsByYear W29147920392022 @default.
• W2914792039 countsByYear W29147920392023 @default.
• W2914792039 crossrefType "journal-article" @default.
• W2914792039 hasAuthorship W2914792039A5000965108 @default.
• W2914792039 hasAuthorship W2914792039A5003919302 @default.
• W2914792039 hasAuthorship W2914792039A5004243536 @default.
• W2914792039 hasAuthorship W2914792039A5004780683 @default.
• W2914792039 hasAuthorship W2914792039A5020254575 @default.
• W2914792039 hasAuthorship W2914792039A5034618391 @default.
• W2914792039 hasAuthorship W2914792039A5062251921 @default.
• W2914792039 hasBestOaLocation W29147920391 @default.
• W2914792039 hasConcept C121608353 @default.
• W2914792039 hasConcept C126322002 @default.
• W2914792039 hasConcept C137620995 @default.
• W2914792039 hasConcept C185592680 @default.
• W2914792039 hasConcept C203014093 @default.
• W2914792039 hasConcept C2776217527 @default.
• W2914792039 hasConcept C2776694085 @default.
• W2914792039 hasConcept C2776816829 @default.
• W2914792039 hasConcept C2779013556 @default.
• W2914792039 hasConcept C2781303535 @default.
• W2914792039 hasConcept C30145163 @default.
• W2914792039 hasConcept C502942594 @default.
• W2914792039 hasConcept C530470458 @default.
• W2914792039 hasConcept C55493867 @default.
• W2914792039 hasConcept C62478195 @default.
• W2914792039 hasConcept C71924100 @default.
• W2914792039 hasConcept C76419328 @default.
• W2914792039 hasConcept C98274493 @default.
• W2914792039 hasConceptScore W2914792039C121608353 @default.
• W2914792039 hasConceptScore W2914792039C126322002 @default.
• W2914792039 hasConceptScore W2914792039C137620995 @default.
• W2914792039 hasConceptScore W2914792039C185592680 @default.
• W2914792039 hasConceptScore W2914792039C203014093 @default.
• W2914792039 hasConceptScore W2914792039C2776217527 @default.
• W2914792039 hasConceptScore W2914792039C2776694085 @default.
• W2914792039 hasConceptScore W2914792039C2776816829 @default.
• W2914792039 hasConceptScore W2914792039C2779013556 @default.
• W2914792039 hasConceptScore W2914792039C2781303535 @default.
• W2914792039 hasConceptScore W2914792039C30145163 @default.
• W2914792039 hasConceptScore W2914792039C502942594 @default.
• W2914792039 hasConceptScore W2914792039C530470458 @default.
• W2914792039 hasConceptScore W2914792039C55493867 @default.
• W2914792039 hasConceptScore W2914792039C62478195 @default.
• W2914792039 hasConceptScore W2914792039C71924100 @default.

• next